[1] 孙悦.阿司匹林肠溶片与双嘧达莫联合用于脑血栓治疗的临床分析[J].中国卫生标准管理,2015,89(7):197~198. [2] Geng Y L,Neurology D O.Clinical trial of clopidogrel tablets combined with aspirin enteric-coated tablets in the treatment of acute ischemic stroke[J].Chinese Journal of Clinical Pharmacology,2016,56(94):121~122. [3] 段丽霞.阿司匹林肠溶片与双嘧达莫联合用于脑血栓治疗的临床价值分析[J].中国现代药物应用,2016,10(17):212~213. [4] Zhang S,Song Y,Naikun L I,et al.Risk factors for aspirin resistance in patients with acute cerebral infarction[J].Shandong Medical Journal,2016,78(77):98~99. [5] 王萍.阿司匹林肠溶片与双嘧达莫联合用于脑血栓治疗的临床效果体会[J].医药卫生:文摘版,2016,90(2):238~239. [6] 赵展宁.阿司匹林肠溶片与双嘧达莫联合用于脑血栓治疗的临床效果评价[J].中国医药指南,2016,14(26):136~137. [7] 傅庆新,边立新.阿司匹林肠溶片联合双嘧达莫治疗脑血栓的临床效果分析[J].世界临床医学,2016,10(8):78~79. [8] Shen H J,He H Y,Dai M X.Observation on the therapeutic effect of aspirin in combined with ozagrel sodium in the treatment of acute cerebral infarction[J].Journal of Hainan Medical University,2017,23(1):90~94. [9] 柳林.阿司匹林肠溶片联合双嘧达莫治疗脑血栓的临床效果[J].世界最新医学信息文摘:连续型电子期刊,2016,16(5):77~78. [10] 程勋矿.阿司匹林肠溶片联合双嘧达莫在脑血栓治疗中的应用价值研究[J].医药卫生:文摘版,2016,96(6):245. [11] Goldstein J L,Whellan D J,Scheiman J M,et al.Long-term safety of a coordinated delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg for secondary cardiovascular disease prevention in patients at GI risk[J].Cardiovascular Therapeutics,2016,34(2):59. [12] 陈翔.浅析脑血栓患者运用双嘧达莫和阿司匹林肠溶片联合治疗的临床疗效[J].中国实用医药,2016,11(9):174~175. [13] Liu G J,Huo Y F,Jiao S F,et al.Clinical study on aspirin enteric-coated tablets combined with complex packing estradiol tablets/estradiol and dydrogesterone tablets in improvement of thin endometrium[J].Drugs&Clinic,2016,45(67):78~79. [14] 彭静玉,任旭东.氯吡格雷联合阿司匹林治疗糖尿病并发急性脑梗死128例分析[J].心理医生,2016,22(27):121~122. [15] Guo W,Lu W,Xu Y,et al.Relationship between adverse gastric reactions and the timing of enteric-coated aspirin administration[J].Clinical Drug Investigation,2016,38(75):1~7.
2017, Vol. 23 
冀公网安备13080202000677号